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doi:10.1Objectives: Transfusion-free pediatric cardiac surgery remains a challenge, mainly owing to the mismatch be-
tween the cardiopulmonary bypass (CPB) priming volume and the infants’ blood volume. Within a comprehen-
sive blood-sparing approach, we developed body weight–adjusted miniaturized CPB circuits with priming
volumes of 95, 110, and 200 mL for, respectively, infants weighing less than 3 kg, 3 to 5 kg and 5 to16 kg.
We analyzed the effects of this approach on transfusion requirements and risk factors predisposing for blood
transfusion.
Methods: A total of 288 children with body weights between 1.7 and 15.9 kg were included and divided into 3
groups: No transfusion, postoperative transfusion only, and intraoperative and postoperative transfusion. Groups
were compared by analysis of variance or analysis of variance on ranks. Risk factors predisposing for transfusion
were identified by multivariate logistic regression.
Results: Of the infants, 24.7% required no transfusion, 23.6% received postoperative transfusion only and
51.7% received intraoperative and postoperative transfusion. Groups differed by age, body weight, and size
and by duration of surgery, CPB, and aortic crossclamp (P<.00001). Body weight (P<.00001), CPB duration
(P<.00001), and persisting cyanosis (P ¼ .03) were predictors of intraoperative and postoperative transfusion,
whereas body weight (P ¼ .00095), reoperations (P ¼ .0051), and cyanotic heart defects (P ¼ .035) were asso-
ciated with postoperative transfusion only.
Conclusions:Our blood-sparing approach allows for transfusion-free surgery in a substantial number of infants.
The strongest predictors of transfusion requirement, body weight and complexity of surgery as reflected by CPB
duration, are not amenable to further improvements. Better preservation of the coagulatory system might allow
for reduction of postoperative transfusion requirements. (J Thorac Cardiovasc Surg 2012;144:493-9)In the past decades pediatric cardiac surgery underwent nu-
merous improvements in surgical techniques, cardiopulmo-
nary bypass (CPB) equipment, and postoperative intensive
care. Yet, transfusion of homologous blood products is still
required in most cases mostly because of the mismatch
between the priming volumes of the CPB circuits and the
patients’ blood volumes. In the general population, transfu-
sion, albeit necessary for maintenance of adequate oxygen
transport, may increase the risks for postoperative compli-
cations such as transfusion-transmitted infection1,2 or
postoperative mortality.3,4 Previous studies confirmed
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Min pediatric cardiac surgery by demonstrating a link be-
tween the amount of transfused blood with the length of
hospital stay5 or the duration of assisted ventilation.6,7 To
minimize the requirement for transfusion of homologous
blood products, we developed a comprehensive blood-
sparing approach that includes the following: (1) avoiding
all unnecessary blood sampling; (2) meticulous surgical
technique aimed at minimizing blood loss; (3) cell salvage
technique and retransfusion of autologous red blood cells;
(4) a defined transfusion trigger of hemoglobin concentra-
tion less than 7 g/dL during CPB while monitoring cerebral
oxygenation by near-infrared spectroscopy to detect and
avoid cerebral hypoxia8; and, most important, (5) minimiz-
ing the priming volume of the CPB circuit while maintain-
ing all necessary safety features.9 Here we report the impact
of this approach on the requirements for transfusion of ho-
mologous blood products in 288 pediatric patients with
body weights of less than 16 kg treated with this approach
at our institution between May 2007 and September 2010.
In addition, the factors that predict blood transfusion
when using our blood-sparing approach are retrospectively
analyzed.rdiovascular Surgery c Volume 144, Number 2 493
TABLE 1. Primary diagnoses
Primary diagnosis No.
Atrial septal defect 21
Ventricular septal defect 48
Atrioventricular septal defect 42
Sinus venosus defect 7
Transposition of the great arteries 39
Hypoplastic left heart syndrome 13
Tetralogy of Fallot 23
Double-outlet right ventricle 6
Persistent Truncus arteriosus 4
Pulmonary atresia 12
Tricuspid atresia 4
Total anomalous pulmonary venous connection 4
Aortic stenosis (4 supravalvular) 11
Hypoplastic aortic arch 7
Others 47
Only primary diagnoses are listed. Most infants presented with combined congenital
heart defects.
Abbreviations and Acronyms
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
RACHS ¼ Risk Adjustment in Congenital Heart
Surgery
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Patients
Between May 2007 and September 2010, 1120 infants with body
weights of less than 16 kg were operated on at our institution for various
indications, 822 with the use of CPB. Of these 1120 infants, 288 were
treated by our team of 1 cardiac surgeon, 1 anesthetist, and 1 of 2 perfusion-
ists dedicated to the blood-sparing approach. Primary diagnoses are listed
in Table 1; however, the majority of patients had combined cardiac defects.
Age ranged from 3 days to 4.8 years, median 161 days (Table 2), and body
weight from 1.7 to 15.9 kg, median 5.8 kg. Fifty-two (18%) procedures
were reoperations, 156 (54%) infants had cyanotic heart defects, and 25
(9%) infants remained cyanotic after surgery. The retrospective data anal-
ysis was approved by the institutional review board.
CPB and Surgery
Two different body weight–adapted CPB circuits were redesigned to
minimize as much as possible the priming volumes. The CPB circuit
used for infants with body weights of less than 5 kg has recently been
described.9,10
A St€ockert S5mast mounted console (St€ockert Instrumente GmbH,Mu-
nich, Germany) was modified by shortening as much as possible all tubing
connections. All tubings were 3/16 inch internal diameter (ID) except the
arterial pump boot (1/4 inch) and suction lines (1/8 inch). Low prime oxy-
genator (KIDSD100; Sorin, Mirandola, Italy) and arterial line filter (D130,
Sorin) were used. Vacuum assist was used to increase venous return. This
modified system has a total priming volume of 110 mL, which was further
reduced to 95 ml for neonates<3 kg body weight by using 3/16 inch ID
tubing for the arterial pump boot.
Because of the flow limitation of this system, the CPB circuit was mod-
ified for infants with body weights between 5 and 16 kg by replacing the
oxygenator (Capiox Baby RX05; Terumo Cardiovascular Systems, Ann
Arbor, Mich) and the arterial line filter (D736; Sorin, Mirandola, Italy), re-
sulting in a priming volume of 200 mL.11
Asanguineous priming of the CPB was used when the estimated hemo-
globin concentration remained above 7 g/dL. Hemoglobin concentrations
were assessed immediately after mixing of the priming volumewith the pa-
tients’ blood, and packed red blood cells were added when the transfusion
trigger of a hemoglobin level less than 7 g/dL was reached. Tranexamic
acid in a dose of 10mg $ kg1 $ h1 was added for antifibrinolysis. Moderate
hypothermia to various degrees was induced according to the expected du-
ration of CPB. Deep hypothermia to 14C to 17C was induced for deep
hypothermic circulatory arrest (DHCA; n ¼ 31). Postoperative transfusion
of homologous blood products was performed on the decision of the attend-
ing physicians. Decreased hemoglobin concentration owing to blood loss
and hemodynamic instability were the major indications for transfusion.
Monitoring
Heart rate, arterial and central venous pressure, pulse-oximetric oxygen
saturation, and temperatures were continuously recorded. Arterial blood
gases and lactate concentrations were analyzed (Rapidlab 865; Siemens
Healthcare Diagnostics, Inc, Deerfield, Ill) before surgery, after the onset494 The Journal of Thoracic and Cardiovascular Surgof CPB, at variable intervals during CPB, briefly before termination of
CPB, and during chest closure (after CPB). Central venous blood gases
were analyzed before CPB and after surgery.
Statistics
Patient characteristics and outcome data were compared between
groups by analysis of variance on ranks. Incidence data were analyzed
by the c2 test. Time course of hemoglobin concentrations among groups
was analyzed by 2-way repeated measures analysis of variance. Predictors
of transfusion were determined by univariate logistic regression. All pa-
rameters with P<.1 in univariate analyses were included in a multivariate
logistic regression model. Because of substantial collinearity among age,
size, and bodyweight as well as among duration of surgery, CPB, and aortic
crossclamp, only the parameters that best predicted transfusion in univari-
ate analyses (ie, body weight and duration of CPB) were included in the
multivariate analyses.RESULTS
In 139 (48.3%) patients surgery could be completed
without blood transfusion, but 68 of these received transfu-
sion of homologous blood products during the postoperative
period. Accordingly, patients were assigned to 3 different
groups: no transfusion (n ¼ 71; 24.7%), postoperative
transfusion only (n ¼ 68; 23.6%), and intraoperative and
postoperative transfusion (n ¼ 149; 51.7%). Distribution
of body weight among these groups is given in Figure 1.
Patient data according to these groups are listed in Table 2.
Infants who required blood transfusions were significantly
younger, smaller, and lighter than those who did not
and, also, those who received intraoperative and postop-
erative transfusion were smaller and lighter than those who
received postoperative transfusion only. Similarly, com-
plexity of surgery, reflected as durations of surgery, CPB,
and aortic crossclamp, was greatest in the infants requiring
intraoperative and postoperative transfusions, followed by
those requiring postoperative transfusions only. The rates
of reoperations were similar among groups, but DHCAery c August 2012
TABLE 2. Patient and procedural data
No transfusion Postop transfusion only Intraop and postop transfusions P value
N (%) 71 (24.7) 68 (23.6) 149 (51.7)
Age (d) 600 (234;946) 151 (95;334)* 114 (42;200)* <.00001
Body weight (kg) 9.7 (6.7;12.6) 6.0 (4.2;8.7)* 4.9 (3.6;6.5)*,y <.00001
Size (cm) 81 (68;93) 64 (55;75)* 58 (53;66)*,y <.00001
Duration of operation (min) 118 (96;147) 149 (113;197)* 189 (149;253)*,y <.00001
CPB duration (min) 57 (38;82) 78 (54;113)* 115 (82;162)*,y <.00001
Crossclamp time (min) 34 (21;52) 53 (28;77)* 59 (38;87)* <.00001
Reop, N (%) 9 (12.7) 16 (23.5) 27 (18.1) .251
DHCA, N (%) 1 (1.4) 2 (2.9) 28 (18.8)*,y .00003
Preop cyanosis, N (%) 17 (23.9) 41 (60.3)* 98 (65.8)* <.00001
Persistent cyanosis, N (%) 3 (4.2) 4 (5.9) 18 (12.1) .10
PRBC, N (%) 66 (97) 149 (100) n.d.
Volume (mL/kg) 23 (19;30) 38 (26;67) <.00001
FFP, N (%) 25 (37) 137 (92) <.00001
TC, N (%) 2 (3) 48 (32) <.00001
Continuous data are represented as median and (25;75) percentiles, rates as absolute numbers N and (%). Groups were compared by analysis of variance on ranks and c2 test
as appropriate. CPB, Cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; PRBC, packed red blood cells; FFP, fresh frozen plasma; TC, thrombocyte
concentrates; n.d., not determined. *P<.05 versus no transfusion. yP<.05 versus postoperative transfusion only.
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Mwas more frequently used in infants who required intraoper-
ative and postoperative transfusions. In both groups with
transfusion, cyanotic heart defects were more frequent,
and there was a trend for more frequent persisting cyanosis
in the group with intraoperative and postoperative transfu-
sion. Total transfused volume of packed red blood cells
and the number of infants who additionally received fresh
frozen plasma or thrombocyte concentrates were signifi-
cantly lower in the group with postoperative transfusion
only versus intraoperative and postoperative transfusion.
The time course of hemoglobin concentrations during
surgery is shown in Figure 2. Hemoglobin concentration
was similar among groups before surgery and decreased
markedly in all groups during CPB. Toward the end of sur-
gery, hemoglobin concentration slightly increased from its
nadir during CPB in the groups without intraoperative trans-
fusion, but it did not reach the preoperative values. In con-
trast, in the transfused group, hemoglobin concentration
started to increase already toward the end of CPB and
was not different from the preoperative value at the end of
surgery.
To assess the parameters that might determine the need
for either intraoperative and postoperative transfusion or
postoperative transfusion only, we applied univariate logis-
tic regression (Table 3). Age, body weight, and size were
negatively correlated with transfusion. Namely, each addi-
tional kilogram of body weight was associated with an
odds ratio (confidence interval [CI]; P value) of 0.77 (CI,
0.71-0.84; P<.00001) for intraoperative and postoperative
transfusion and 0.81 (CI, 0.73-0.89; P¼ .00004) for postop-
erative transfusion only. Preoperative hemoglobin concen-
tration was not associated with transfusion nor
did postoperative hemoglobin concentration affect the
need for postoperative transfusion. Reoperations tended toThe Journal of Thoracic and Caincrease the risk for postoperative transfusion only
(P ¼ .10). The complexity of surgery, assessed by duration
of surgery, CPB, and aortic crossclamp, strongly deter-
mined the need for transfusion. Namely, each additional
minute of CBP was associated with an odds ratio of 1.02
(CI, 1.01-1.03; P<.00001) for intraoperative and postoper-
ative transfusion and 1.02 (CI, 1.01-1.03; P ¼ .00038) for
postoperative transfusion only. DHCA markedly increased
the need for intraoperative and postoperative transfusion
(odds ratio, 10.49; CI, 3.11-35.38; P¼ .00015) but not post-
operative transfusion only (P ¼ .54). Infants with cyanotic
heart defects had a higher need for intraoperative and post-
operative transfusion (odds ratio, 2.68; CI, 1.66-4.33;
P¼ .00005) and postoperative transfusion only (odds ratio,
4.82; CI, 2.32-10.01; P ¼ .00002). Palliative surgery with
persisting cyanosis was associated with a higher need for in-
traoperative and postoperative transfusion(odds ratio, 3.65;
CI,1.32-10.08; P ¼ .012) but not for postoperative transfu-
sion only requirement (P ¼ .66).
To assess which parameters independently predicted the
need for blood transfusion, we used multivariate logistic
regression (Table 3, lower part). All parameters with
P¼ .10 or smaller in one of the univariate analyses were in-
cluded in the multivariate model, except for age and size be-
cause of colinearity with body weight, and duration of
surgery and aortic crossclamp because of colinearity with
CPB duration. Independent predictors of the need for intrao-
perative and postoperative transfusion were body weight,
CPB duration, and palliative surgery with persisting cyano-
sis, but not DHCA or cyanotic heart defects. Predictors for
postoperative transfusion only were body weight, reopera-
tions, and cyanotic heart defects. Complexity of surgery as
reflected by CPB duration showed a strong trend to also in-
crease the need for postoperative transfusion only (P¼ .072).rdiovascular Surgery c Volume 144, Number 2 495
FIGURE 1. Distribution of infants among the groups with no transfusion,
postoperative transfusion only, and intraoperative and postoperative trans-
fusion is analyzed according to body weight. While 26% of neonates in the
lowest weight group were operated on without blood transfusion, only 8%
remained without any transfusion also in the postoperative period. This rate
increased continuously with body weight to 60% among infants with body
weights between 13 and 16 kg. Conversely, the rate of intraoperative and
postoperative transfusion decreased with body weight, from 74% to 12%.
FIGURE 2. The course of hemoglobin concentrations during surgery is
given for the 3 groups. Data are means  standard error of the mean.
Only time points of major interest, that is, preoperative, CPBmid, and post-
operative, were included in the 2-way repeated measures analysis of vari-
ance. *P<.00001 versus preoperative; *** all 3 groups P<.00001 versus
pre-OP; #P<.01 versus CPB mid; xP<.00001 intraoperative and postop-
erative transfusion versus postoperative transfusion only and no transfu-
sion. Hb, Hemoglobin concentration; CPB, cardiopulmonary bypass.
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MDISCUSSION
Implementation of body weight–adjusted miniaturized
CPB circuits for pediatric cardiac surgery combined with
a comprehensive strategy to avoid unnecessary hemodilu-
tion allowed for completion of surgery without transfusion
of homologous blood products in 48.3% of infants. Includ-
ing the postoperative period, 24.7% of the infants could be
treated without any transfusion. In multivariate logistic re-
gression analyses, low body weight, complexity of surgery
as reflected by duration of CPB, and persisting cyanosis af-
ter palliative surgery were independent predictors for intra-
operative and postoperative transfusion. Postoperative
transfusion only was independently associated with low
body weight, reoperations, and cyanotic heart defects.
Minimizing hemodilution in pediatric cardiac surgery
may have several potential benefits. Oxygen transport ca-
pacity is maintained and the coagulatory system is better
preserved, which may reduce postoperative bleeding.
Most important, it may help to avoid intraoperative or post-
operative transfusion of homologous blood products. Trans-
fusion is generally associated with a number of risks
including transmission of infectious agents,12 inflammatory
responses,13,14 or transfusion-related acute lung injury.15,16
In the setting of pediatric cardiac surgery, transfusion has
recently been associated with adverse short-term outcome496 The Journal of Thoracic and Cardiovascular Surgsuch as increased rate of infection,17 length of mechanical
ventilation,6,7 and length of hospital stay.5
Accordingly, several successful attempts to avoid trans-
fusion in pediatric cardiac surgery by using miniaturized
CPB circuits and stringent transfusion triggers have been re-
ported.18-21 The major differences in the present approach
are that the priming volumes of the CBP circuits used are
considerably smaller and, in addition to intraoperative
transfusion, incidence of postoperative transfusion was
analyzed as well. Also, in some of the previous reports
only infants with low-complexity surgery such as closure
of ventricular septal defect were included,19 and important
safety features such as arterial line filter were eliminated.19
In some studies transfusion-trigger hematocrit was rather
low at 15%,18,19 although the hemoglobin concentration
of 7 g/dL triggering transfusion in the present study would
correspond to a hematocrit value of 21%. The single study
that is best comparable with the present report by the
mixed patient population and a transfusion trigger of
hematocrit value less than 20% is by Kotani and
associates.20 They used CPB circuits with priming volumes
of 300 and 500 mL and completed surgery without transfu-
sion in 49.3% of the infants, which is about the same as the
48.3% in the present study. Thus it would seem that the fur-
ther reduction of priming volumes had little effect on trans-
fusion requirements. However, the median age and body
weight in that studywere 23.5months (range, 2-124months)
and 10.4 kg (range, 5.0-19.9 kg) compared with 5.4 months
(range, 0-58months) and 5.8 kg (range, 1.7-15.9 kg), respec-
tively, in the present study. Considering the strongery c August 2012
TABLE 3. Risk factors for transfusion results of logistic regression analyses to determine the risk factors predisposing for intraoperative and
postoperative transfusion and postoperative transfusion only
Intraop and postop transfusion Postop transfusion only
Odds ratio; CI P value Odds ratio; CI P value
Univariate logistic regression
Age (y) 0.43; 0.32-0.57 <.00001 0.59; 0.44-0.79 .00036
BW (kg) 0.77; 0.71-0.84 <.00001 0.81; 0.73-0.89 .00004
Size (cm) 0.94; 0.92-0.96 <.00001 0.95; 0.93-0.97 .00002
Reop 1.01; 0.55-1.84 .98 2.12; 0.87-5.19 .10
Preop hemoglobin (g/dL) 0.99; 0.89-1.10 .81 1.18; 0.99-1.40 .065
Postop hemoglobin (g/dL) n.d. n.d. 0.87; 0.69-1.09 .22
Op duration (min) 1.02; 1.01-1.02 <.00001 1.02; 1.01-1.03 .00015
CPB duration (min) 1.02; 1.01-1.03 <.00001 1.02; 1.01-1.03 .00038
Crosslamp time (min) 1.01; 1.01-1.02 .00005 1.02; 1.00-1.03 .0052
DHCA 10.49; 3.11-35.38 .00015 2.12; 0.18-23.95 .54
Preop cyanosis 2.68; 1.66-4.33 .00005 4.82; 2.32-10.01 .00002
Persist. cyanosis 3.65; 1.32-10.08 .012 1.42; 0.31-6.58 .66
Multivariate logistic regression
BW (kg) 0.80; 0.73-0.88 <.00001 0.80; 0.70-0.91 .00095
CPB duration (min) 1.02; 1.01-1.02 <.00001 1.01; 1.00-1.02 .072
Reop n.d. n.d. 6.01; 1.71-21.05 .0051
Preop hemoglobin (g/dL) n.d. n.d. 0.82; 0.62-1.07 .14
DHCA 1.91; 0.50-7.31 .34 1.17; 0.08-17.67 .91
Preop cyanosis 1.07; 0.56-2.03 .84 3.46; 1.09-10.98 .035
Persist. cyanosis 3.44; 1.12-10.59 .03 n.d. n.d.
Only parameters with P<.1 in the univariate analyses were included in the multivariate logistic regression models. P values<.05 in multivariate analyses are given in boldface
type. CI, Confidence interval; BW, body weight; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; n.d., not determined.
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ments reported in previous studies17,20 and the present study,
we may conclude that the smaller CPB circuits used in the
present study allowed for a similar rate of transfusion-free
surgery in a much younger and smaller patient population
than in that previous report. This conclusion is supported
by comparison of intraoperative transfusion rates by body
weight–based analysis. Whereas the smallest child in the
study by Kotani and associates20 had a body weight of 5
kg, our population included 137 infants with body weights
of 1.7 to 5 kg and 30% of these concluded cardiac surgery
without transfusion. In the weight group of 6 to 10 kg,
transfusion-free surgery was achieved in 57% of 95 infants
compared with 29% of 279 infants in the report by Kotani
and associates,20 whereas the transfusion-free rate in the
group with 11 to 15 kg was 79% of 56 infants in our study
compared with 67% of 184 patients in the previous study.
Miyaji and colleagues21 used a CPB circuit with a prim-
ing volume of 140 mL for infants with 4- to 7-kg body
weight and achieved transfusion-free surgery in an impres-
sive 64% of 70 patients with mixed diagnoses. The main
transfusion trigger was a hematocrit value of less than
20%, which is similar to our study. The major differences
that might contribute to the greater rate of transfusion-free
surgery despite the larger priming volume are the number
of infants with body weight of less than 4 kg in our patient
population (74/288) and the larger rate of less complexThe Journal of Thoracic and Casurgical procedures (35/70 patients received only ventricu-
lar or atrial septal defect closure) in that previous study.
The second focus of this study was to determine the risk
factors for intraoperative and postoperative transfusion to
identify additional interventions that might help to reduce
the rate of blood transfusions. Previously, Szekely and co-
workers17 performedmultivariate linear regression analyses
to determine the predictors of the volume of transfused ho-
mologous blood products (until 24 hours after surgery) in
a mixed population of infants who were operated on with
conventional CPB circuits (priming volume not given). In
accordance with our results, they identified body weight
and crossclamp time as strong predictors of transfused vol-
ume. Similar to the present study, Kotani,20 Miyaji,21 and
their associates used multivariate logistic regression analy-
sis to determine the risk factors for intraoperative transfu-
sion and also identified body weight and CPB time as
strong independent predictors. Preoperative hematocrit
value was associated with the need for transfusion in only
1 of these studies.20 This was not confirmed in the present
study, in which preoperative hemoglobin concentration
was not different among groups (Figure 2) and did not affect
the rate of transfusion. This is in contrast to a recent study on
neonates undergoing the arterial switch operation for trans-
position of the great arteries, in which hemoglobin concen-
tration was significantly lower in infants requiring
intraoperative transfusion.9 We, therefore, analyzed therdiovascular Surgery c Volume 144, Number 2 497
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Msubgroup with cyanotic heart defects in more detail. Hemo-
globin concentration in cyanotic infants was significantly
higher than in the noncyanotic group (12.7  2.2 vs 10.7
 1.5; P<.00001 rank sum test). Within the noncyanotic
group, preoperative hemoglobin concentration was similar
in infants receiving no transfusion (10.8  0.8), postopera-
tive transfusion only (10.5 1.3), or intraoperative and post-
operative transfusion (10.7  2.1). In contrast, in the
cyanotic group, preoperative hemoglobin concentration
was significantly higher in the group with no transfusion
(13.7  1.9) than in the group with intraoperative and post-
operative transfusion (12.3 2.2), whereas the value for in-
fants with postoperative transfusion only was in between
(13.2  2.2; P ¼ .005, analysis of variance on ranks). Ac-
cordingly, univariate logistic regression within the subgroup
of cyanotic infants indicates significant influence of preoper-
ative hemoglobin concentration on the need for intraopera-
tive and postoperative transfusion (odds ratio 0.81; CI,
0.70-0.95; P ¼ .0076) but not for postoperative transfusion
only (P¼ .42). Because they constitute the major difference
between this and previous studies, it seems that the very low
priming volume CPB circuits used in the present study
lessen the influence of preoperative hemoglobin concentra-
tion on intraoperative transfusion requirements. However,
further studies would be needed to confirm this speculation.
The only additional independent predictor of intraoperative
and postoperative transfusion was palliative surgery with
persisting cyanosis present in 25 infants, which is not sur-
prising, because a higher target hemoglobin concentration
on weaning fromCPB is necessary in these patients to main-
tain sufficient oxygen delivery despite reduced oxygen sat-
uration. Accordingly, 72% of these infants received
intraoperative and postoperative transfusion, 16% postoper-
ative transfusion only, and only 12% remained without any
transfusion. These infants may also contribute to the in-
crease in hemoglobin concentration toward the end of
CPB and the end of surgery (Figure 2).
For the analysis of risk factors for postoperative transfu-
sion only in the subgroup of infants who completed surgery
without transfusion, we are not aware of any previous stud-
ies addressing this question. Low body weight also in-
creased the risk of transfusion, whereas CPB time, which
we consider to reflect the complexity of surgery, did not.
That would indicate that the complexity of surgery has
a stronger influence on intraoperative than on postoperative
transfusion requirements. Reoperations were identified as
a strong independent predictor of postoperative transfusion
only with an odds ratio of 6.01 (CI, 1.71-21.05). Although
postoperative blood loss was not monitored in this study,
we should ascribe this observation to the greater risk of
bleeding in these patients. Why preoperative cyanosis,
which is corrected during surgery, should increase the trans-
fusion requirements during the postoperative period re-
mains unclear.498 The Journal of Thoracic and Cardiovascular SurgLimitations
The general limitations of retrospective analyses have re-
cently been summarized22 and include the ‘‘inability to (1)
harvest data on all important covariates (variables or risk
factors), (2) control covariates, and (3) standardize indica-
tions for the primary intervention’’ and apply to the present
study as well. A large prospective study with a well-
standardized clinical approach, standardized transfusion
triggers, and careful selection of potential risk factors deter-
mining the rate of transfusion would be necessary to avoid
this problem. Another limitation may be the selection of
CPB time to reflect the complexity of cardiac surgery. Pre-
vious studies determined the Risk Adjustment in Congenital
Heart Surgery (RACHS) category for this purpose.17,20,21
However, in contrast to CPB time, in all these studies
RACHS category was associated with transfusion only in
the univariate, but not in the multivariate, analyses and we
conclude that CPB time may better represent the impact
of the surgical complexity on transfusion requirements
than the RACHS category. Although the risks of
transfusion of blood products are widely known, clinical
outcome was not assessed in this study, which focused on
the ability to avoid blood transfusion by using a very low
priming volume CPB circuit and on the risk factors for
intraoperative and postoperative transfusion with this
approach. Finally, there are no unanimous data on the safe
hematocrit or hemoglobin level in neonates or infants
during CPB.9 Lower psychomotor development has been
associated with a hematocrit level during CPB of less
than 22%23-25 or less than 23.5%.26 On the other hand, a he-
matocrit level of 20% as a transfusion trigger did not seem
to negatively affect psychomotor development in another,
albeit retrospective, study.21 In a large prospective study
in critically ill infants, a transfusion trigger of 7.0 g/dL he-
moglobin concentration was not inferior to a trigger of 9.5
g/dL concerning clinical outcome.27 In a subgroup analysis,
similar results were obtained for infants who had undergone
cardiac surgery.28 Although psychomotor development was
not included in the outcome parameters and the situation of
infants on intensive care units is not directly comparable
with the situation of CPB, one might speculate that during
the latter condition infants are at less risk of hypoxia be-
cause oxygen delivery is well monitored and controlled
via the CPB flow rate.While the hematocrit transfusion trig-
ger of 21% in our protocol is in between these values, one
must also appreciate that cerebral balance of oxygen deliv-
ery to demand depends not only on hematocrit but also on
CPB flow rate and temperature, which also differ among
these studies.CONCLUSIONS
In conclusion, we demonstrated that use of body weight–
adjusted low-volume CPB circuits with a minimal primingery c August 2012
Redlin et al Perioperative Managementvolume of down to 95 mL allows for completion of cardiac
surgery without transfusion in nearly 50% of infants in
a mixed patient population with body weights between
1.7 and 16 kg and variable surgical complexity. Nearly
25% of these infants remained without transfusion during
the whole postoperative period. The concerted effort of sur-
geon, anesthetist, and perfusionist to avoid transfusion was
pivotal to achieve these results, in addition to the low-
volume CPB circuits. Body weight, CPB time, and pallia-
tive surgery with persisting cyanosis were independent
predictors of intraoperative transfusion. In the subgroup of
infants without intraoperative transfusion, body weight, re-
operation, and cyanotic heart defects determined the need
for postoperative transfusion. None of these risk factors
seems easily amenable to interventions with the goal of
further reducing transfusion rates. Thus transfusion-free
pediatric cardiac surgery remains a challenge, especially
in low-weight infants. Better preservation of the coagula-
tory system by improved biocompability of the CPB circuits
might reduce postoperative bleeding and transfusion
requirements during this period. Further research should ad-
dress the safety of such approaches using very low priming
volume CPB circuits and assess the safe hematocrit concen-
tration during different CPB flow and temperature
conditions.
We acknowledge the meticulous work of Argid and Raimund
Rutenberg to compile the comprehensive data set for this study.References
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